THE owner of a Northumberland pharmaceutical factory has bought an American rival, creating a global giant, but at the same time said it was axing 16,000 jobs worldwide.
"Minimal or none at all," Merck chief executive Richard Clark said about the impact of the proposed merger on his company's three Montgomery County facilities.
The two companies do not overlap in Pennsylvania, said Clark, who lives in Doylestown. He also said Merck's local operations, most notably its vaccine manufacturing facility in West Point, belonged to a business line the company was counting on for growth.
Big drug companies are facing the expiration of billions of dollars of patents in the next few years. The Obama administration also is pushing changes that would favor cheaper generic companies. The result: Many pharmaceutical companies are looking for a partner to lean on in tough times.
Mas...
Entradas
2 comentarios:
Fernando, aunque el comentario no va sobre el post del que cuelga, he visto que has participado en un acto que la plataforma "No Gracias" ha divulgado en su web. ¿Qué tal fue? ¿Nos podrías comentar algo? (hago ahora de periodista, no sé si te das cuenta, jeje!). En la web de la plataforma no hacen más que la mera alusión...
Un abrazo,
enrique
Bienvenido Enrique. Efectivamente participé junto con Carlos Ponte en un evento organizado por los alumnos de medicina de la Universidad de Oviedo.
La nota sale el 19 de febrero y el link
http://pharmacoserias.blogspot.com/2009/02/industria-farmaceutica-vs-salud-publica.html
Un fuerte abrazo y una linda primavera en flor que tanta envidia me dá de esas tierras.
Publicar un comentario